Acorn Capital Advisors, LLC Portfolio Holdings

Acorn Capital Advisors, LLC has filed its 13F form on May 15, 2025 for Q1 2025 where it was disclosed a total value porftolio of $144 Billion distributed in 22 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Cg Oncology Inc with a value of $27.7B, Uro Gen Pharma Ltd. with a value of $16.8B, Y M Abs Therapeutics, Inc. with a value of $14.3B, Trevi Therapeutics, Inc. with a value of $13.5B, and Candel Therapeutics, Inc. with a value of $12.2B.

Examining the 13F form we can see an decrease of $46.8B in the current position value, from $190B to 144B.

Acorn Capital Advisors, LLC is based out at New York, NY

Below you can find more details about Acorn Capital Advisors, LLC portfolio as well as his latest detailed transactions.